SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 169.71 |
| Enterprise Value ($M) | 166.68 |
| Book Value ($M) | 40.72 |
| Book Value / Share | 0.95 |
| Price / Book | 4.17 |
| NCAV ($M) | 38.98 |
| NCAV / Share | 0.91 |
| Price / NCAV | 4.35 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.60 |
| Return on Assets (ROA) | -0.50 |
| Return on Equity (ROE) | -0.53 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.28 |
| Current Ratio | 8.28 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 44.61 |
| Assets | 46.34 |
| Liabilities | 5.63 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -26.68 |
| Net Income | -24.44 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -22.08 |
| Cash from Investing | 8.56 |
| Cash from Financing | 11.99 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Dialectic Capital Management, Lp | 5.20 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,718 | 84,551 | 19.77 | |
| 42,445 | 127,648 | 33.25 | |
| 20,737 | 126,527 | 16.39 | |
| 10,494 | 87,533 | 11.99 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CYRX – Cryoport, Inc. | DARE – Daré Bioscience, Inc. |
| DERM – Journey Medical Corporation | DNTH – Dianthus Therapeutics, Inc. |
| DRMA – Dermata Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io